jose C. herrera garcia, “The Benefit and clinical characteristics after use of Nintedanib in Idiopathic Pulmonary Fibrosis: Benefit and clinical characteristics after use of Nintedanib in Idiopathic Pulmonary Fibrosis”, J Med Rev, vol. 2, no. 4, pp. Page No. : 283–285, Apr. 2019.